Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893))

P. G. Pappas, C. M.F. Rotstein, R. F. Betts, M. Nucci, D. Talwar, J. J. De Waele, J. A. Vazquez, B. F. Dupont, D. L. Horn, L. Ostrosky-Zeichner, A. C. Reboli, B. Suh, R. Digumarti, C. Wu, L. L. Kovanda, L. J. Arnold, D. N. Buell

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Number of pages1
    JournalClinical Infectious Diseases
    Volume47
    Issue number2
    DOIs
    StatePublished - Jul 15 2008

    All Science Journal Classification (ASJC) codes

    • Microbiology (medical)
    • Infectious Diseases

    Cite this

    Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., Reboli, A. C., Suh, B., Digumarti, R., Wu, C., Kovanda, L. L., Arnold, L. J., & Buell, D. N. (2008). Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893)). Clinical Infectious Diseases, 47(2). https://doi.org/10.1086/590000